|
EP4282419A1
(en)
|
2012-12-20 |
2023-11-29 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
|
AU2013204922B2
(en)
|
2012-12-20 |
2015-05-14 |
Celgene Corporation |
Chimeric antigen receptors
|
|
JP6493692B2
(ja)
|
2013-03-15 |
2019-04-10 |
セルジーン コーポレイション |
修飾されたｔリンパ球
|
|
DK3143134T3
(da)
|
2014-05-15 |
2021-01-04 |
Nat Univ Singapore |
Modificerede, naturlige dræberceller og anvendelser deraf
|
|
AU2015305449B2
(en)
*
|
2014-08-22 |
2021-05-06 |
Celgene Corporation |
Methods of treating multiple myeloma with immunomodulatory compounds in combination with antibodies
|
|
UA124450C2
(uk)
|
2014-12-01 |
2021-09-22 |
Самма Хелт |
Спосіб індукції відновлення серця або міокарда або поліпшення функції вказаного серця або міокарда пацієнта
|
|
CA2973878A1
(en)
|
2015-01-22 |
2016-07-28 |
University Of Massachusetts |
Cancer immunotherapy
|
|
MA53355A
(fr)
|
2015-05-29 |
2022-03-16 |
Agenus Inc |
Anticorps anti-ctla-4 et leurs procédés d'utilisation
|
|
US12590321B2
(en)
|
2016-03-19 |
2026-03-31 |
Exuma Biotech Corp. |
Methods and compositions for genetically modifying and expanding lymphocytes and regulating the activity thereof
|
|
US11111505B2
(en)
|
2016-03-19 |
2021-09-07 |
Exuma Biotech, Corp. |
Methods and compositions for transducing lymphocytes and regulating the activity thereof
|
|
US11325948B2
(en)
|
2016-03-19 |
2022-05-10 |
Exuma Biotech Corp. |
Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of MPL
|
|
EP3439675A4
(en)
|
2016-04-08 |
2019-12-18 |
Purdue Research Foundation |
METHOD AND COMPOSITIONS FOR CAR-T CELL THERAPY
|
|
JP7158104B2
(ja)
*
|
2016-07-15 |
2022-10-21 |
ビラクタ セラピューティクス，インク． |
Ｎｋ細胞ベースの療法で使用するためのｈｄａｃ阻害剤
|
|
JP7066696B2
(ja)
|
2016-10-11 |
2022-05-13 |
アジェナス インコーポレイテッド |
抗ｌａｇ－３抗体及びその使用方法
|
|
US11459568B2
(en)
|
2016-10-31 |
2022-10-04 |
University Of Massachusetts |
Targeting microRNA-101-3p in cancer therapy
|
|
CN110300599B
(zh)
|
2016-12-07 |
2024-07-02 |
艾吉纳斯公司 |
抗体和其使用方法
|
|
DK3551660T5
(da)
|
2016-12-07 |
2024-09-02 |
Agenus Inc |
Anti-ctla-4-antistoffer og fremgangsmåder til anvendelse deraf
|
|
WO2018104562A1
(en)
|
2016-12-09 |
2018-06-14 |
Onkimmune Limited |
Engineered natural killer cells and uses thereof
|
|
WO2018121679A1
(zh)
*
|
2016-12-30 |
2018-07-05 |
四川大学 |
表达cxcr4的嵌合抗原受体修饰的淋巴细胞及制备方法和用途
|
|
WO2018160622A1
(en)
|
2017-02-28 |
2018-09-07 |
Endocyte, Inc. |
Compositions and methods for car t cell therapy
|
|
BR112019019917A2
(pt)
|
2017-03-27 |
2020-04-22 |
Nat Univ Singapore |
receptores quiméricos nkg2d truncados e seus usos em imunoterapia de células exterminadoras naturais
|
|
US12129487B2
(en)
*
|
2017-03-27 |
2024-10-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method to obtain lymphoid progenitors
|
|
CA3056591A1
(en)
|
2017-03-27 |
2018-10-04 |
National University Of Singapore |
Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
|
|
EP3630144A4
(en)
*
|
2017-05-25 |
2021-03-31 |
University of Central Florida Research Foundation, Inc. |
NEW ONCOLYTIC VIRUSES TO SENSITIZE TUMOR CELLS TO DESTRUCTION BY NATURAL KILLER CELLS
|
|
TWI676483B
(zh)
*
|
2017-08-06 |
2019-11-11 |
強普生技股份有限公司 |
醫藥套組及其用途
|
|
WO2019067792A1
(en)
*
|
2017-09-28 |
2019-04-04 |
Celularity, Inc. |
TUMOR CONTROL WITH INTERMEDIATE NATURAL KILLER CELLS DERIVED FROM HUMAN PLACENTA (PINK) IN COMBINATION WITH ANTIBODY
|
|
US11834677B2
(en)
*
|
2017-10-02 |
2023-12-05 |
Gamida Cell Ltd. |
Expansion and use of expanded NK cell fractions
|
|
CA3080109A1
(en)
*
|
2017-11-03 |
2019-05-09 |
Sorrento Therapeutics, Inc. |
Cd38-directed chimeric antigen receptor constructs
|
|
KR20200098590A
(ko)
*
|
2017-12-12 |
2020-08-20 |
마크로제닉스, 인크. |
이중특이적 cd16-결합 분자 및 질환 치료에서의 그것의 용도
|
|
CN108060137B
(zh)
*
|
2017-12-26 |
2021-07-02 |
博生吉医药科技(苏州)有限公司 |
Il7和il21修饰的nk92细胞、制备方法及其应用
|
|
WO2019127215A1
(en)
*
|
2017-12-28 |
2019-07-04 |
Nanjing Legend Biotech Co., Ltd. |
Multispecific chimeric receptors comprising an nkg2d domain and methods of use thereof
|
|
IL264068B2
(en)
*
|
2018-01-05 |
2023-07-01 |
Great Novel Therapeutics Biotech & Medicals Corp |
Aggregate and pharmaceutical preparation containing an hdac inhibitor and an nsaid aggregate together with an immune checkpoint inhibitor for use in a method for removing immunosuppression in the microenvironment of a tumor or stimulating an immune system against cancer cells
|
|
US11311576B2
(en)
|
2018-01-22 |
2022-04-26 |
Seattle Children's Hospital |
Methods of use for CAR T cells
|
|
US11814623B2
(en)
|
2018-01-30 |
2023-11-14 |
University Of Massachusetts |
Methods of treating a wound using epigenetic regulation
|
|
IL276365B2
(en)
|
2018-02-01 |
2023-10-01 |
Nkmax Co Ltd |
A method for the production of natural killer cells and a preparation for cancer treatment
|
|
EP3749685A4
(en)
|
2018-02-09 |
2021-12-22 |
National University of Singapore |
ACTIVATOR CHEMERIC RECEPTORS AND THEIR USES IN NATURAL KILLING CELL IMMUNOTHERAPY
|
|
US12473336B2
(en)
|
2018-02-21 |
2025-11-18 |
Board Of Regents, The University Of Texas System |
Methods for activation and expansion of natural killer cells and uses thereof
|
|
AU2019225174B2
(en)
|
2018-02-23 |
2025-11-20 |
Endocyte, Inc. |
Sequencing method for CAR T cell therapy
|
|
WO2019183094A1
(en)
*
|
2018-03-19 |
2019-09-26 |
The Regents Of The University Of Michigan |
Compositions and methods for t-cell and cytokine activation
|
|
JP7334985B2
(ja)
|
2018-04-02 |
2023-08-29 |
ナショナル ユニヴァーシティー オブ シンガポール |
免疫細胞で発現される膜結合抗サイトカイン非シグナル伝達バインダーによるヒトサイトカインの中和
|
|
EP3781182A4
(en)
|
2018-04-18 |
2021-11-17 |
Summa Health |
COMPOSITIONS AND METHODS OF TREATMENT OF ISCHEMIA AND CARDIOMYOPATHIA
|
|
WO2019200586A1
(en)
*
|
2018-04-19 |
2019-10-24 |
The Chinese University Of Hong Kong |
Modified nk cells and uses thereof
|
|
GB201807050D0
(en)
*
|
2018-04-30 |
2018-06-13 |
Cellprotect Nordic Pharmaceuticals Ab |
Medical uses
|
|
KR102373502B1
(ko)
*
|
2018-05-14 |
2022-03-11 |
주식회사 금호에이치티 |
골수유래억제세포 관련 질환의 예방 및 치료 용도
|
|
KR102069704B1
(ko)
*
|
2018-05-16 |
2020-01-23 |
고려대학교 산학협력단 |
Hdac 억제제를 이용한 사람 유래 자연살해세포의 확장 배양법
|
|
KR20210016567A
(ko)
*
|
2018-05-30 |
2021-02-16 |
글리코스템 떼라퓨틱스 비.브이. |
Car nk 세포
|
|
CN112601546B
(zh)
|
2018-06-12 |
2024-04-16 |
湖南远泰生物技术有限公司 |
Plap-car-效应细胞
|
|
CN108815186A
(zh)
*
|
2018-06-14 |
2018-11-16 |
上海鸣大生物科技有限公司 |
一种治疗hpv持续感染引起疾病的药物及制备方法与应用
|
|
EP3844186A4
(en)
|
2018-08-29 |
2022-08-17 |
National University of Singapore |
METHOD OF SPECIFIC STIMULATION OF SURVIVAL AND EXPANSION OF GENETICALLY MODIFIED IMMUNE CELLS
|
|
CA3112788A1
(en)
*
|
2018-09-05 |
2020-03-12 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Oncolytic virus platform to treat hematological cancer
|
|
CN112912400B
(zh)
|
2018-10-19 |
2025-05-30 |
明尼苏达大学董事会 |
Nk接合子分子及其使用方法
|
|
AU2019372673A1
(en)
|
2018-11-01 |
2021-05-27 |
Gracell Biotechnologies (Shanghai) Co., Ltd. |
Compositions and methods for T cell engineering
|
|
CA3120563A1
(en)
|
2018-11-26 |
2020-06-04 |
Nkarta, Inc. |
Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
|
|
KR20210111244A
(ko)
*
|
2018-11-30 |
2021-09-10 |
셀룰래리티 인코포레이티드 |
태반-유래 동종이계 car-t 세포 및 이의 용도
|
|
EP3773918A4
(en)
|
2019-03-05 |
2022-01-05 |
Nkarta, Inc. |
CD19 DIRECTED CHIMERIC ANTIGEN RECEPTORS AND THEIR USES IN IMMUNOTHERAPY
|
|
IL286482B2
(en)
*
|
2019-03-21 |
2025-01-01 |
Gamida Cell Ltd |
Cultured NK cell fractions for use in combination therapy
|
|
TW202110873A
(zh)
|
2019-04-30 |
2021-03-16 |
美商聖堤生物科技股份有限公司 |
嵌合受體及其使用方法
|
|
US20220273716A1
(en)
*
|
2019-07-25 |
2022-09-01 |
Celularity Inc. |
Populations of natural killer cells comprising a cd38 chimeric antigen receptor
|
|
US20220340927A1
(en)
*
|
2019-09-01 |
2022-10-27 |
Exuma Biotech Corp. |
Methods and compositions for the modification and delivery of lymphocytes
|
|
AU2020361622A1
(en)
*
|
2019-10-10 |
2022-04-28 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Oncolytic viruses that express multi-specific immune cell engagers
|
|
WO2021108769A1
(en)
*
|
2019-11-27 |
2021-06-03 |
Deverra Therapeutics Inc. |
Compositions and methods for culturing hematopoietic stem and progenitor cells
|
|
WO2021107779A1
(en)
*
|
2019-11-28 |
2021-06-03 |
Glycostem Therapeutics B.V. |
Method for obtaining car-nk cells
|
|
CN115243713A
(zh)
*
|
2020-03-05 |
2022-10-25 |
埃克苏马生物技术公司 |
用于递送修饰的淋巴细胞聚集体的方法和组合物
|
|
CN115461070A
(zh)
*
|
2020-03-18 |
2022-12-09 |
斯坦福大学托管董事会 |
组织蛋白酶抑制素基因表达的上调作为疾病的其他治疗的辅助
|
|
US20240000937A1
(en)
*
|
2020-09-22 |
2024-01-04 |
World Biotech Regenerative Medical Group Limited |
Methods and compositions of car-expressing natural killer cells with bispecific antigen-binding molecules as cancer therapeutic agents
|
|
US11459372B2
(en)
|
2020-11-30 |
2022-10-04 |
Crispr Therapeutics Ag |
Gene-edited natural killer cells
|
|
WO2022144632A1
(en)
|
2020-12-30 |
2022-07-07 |
Crispr Therapeutics Ag |
Compositions and methods for differentiating stem cells into nk cells
|
|
TW202245598A
(zh)
|
2021-02-09 |
2022-12-01 |
美商千禧製藥公司 |
用於冷凍及解凍哺乳動物細胞的方法及組成物
|
|
AU2022218710A1
(en)
*
|
2021-02-09 |
2023-08-10 |
Takeda Pharmaceutical Company Limited |
Methods and compositions for freezing and thawing mammalian cells
|
|
CN113398264B
(zh)
*
|
2021-08-06 |
2022-04-29 |
朱有建 |
Nk细胞及其组合物在治疗癌症中的用途
|
|
US20240335472A1
(en)
*
|
2021-08-10 |
2024-10-10 |
Gamida Cell Ltd. |
Anti-her2 car nk cells, methods of their production and uses thereof
|
|
CN113577267B
(zh)
*
|
2021-09-06 |
2022-04-08 |
江西北正干细胞生物科技有限公司 |
Nk细胞和抗体的药物组合物及其在治疗癌症中的用途
|
|
JPWO2023038037A1
(https=)
*
|
2021-09-08 |
2023-03-16 |
|
|
|
EP4180049A1
(en)
*
|
2021-11-16 |
2023-05-17 |
Ostravska univerzita |
Therapeutic composition for cancer treatment
|
|
CN114058584B
(zh)
*
|
2022-01-07 |
2022-07-01 |
山东省齐鲁干细胞工程有限公司 |
一种临床用自然杀伤细胞的制备方法
|
|
CN115927169B
(zh)
*
|
2022-10-11 |
2023-08-11 |
再造再生医学科技(杭州)有限公司 |
用于扩增cd34+造血干细胞的培养液和体外扩增cd34+造血干细胞的方法
|
|
CN119082021B
(zh)
*
|
2024-09-30 |
2025-03-28 |
广东壹加再生医学研究院有限公司 |
一种增强型nk细胞及其制备方法
|
|
CN119280423A
(zh)
*
|
2024-10-10 |
2025-01-10 |
中南大学 |
一种联合靶向鼻咽癌治疗的载药体系及其制备方法与应用
|
|
CN121426926A
(zh)
*
|
2025-10-21 |
2026-01-30 |
北京京科信拓生物技术有限公司 |
基因编辑的免疫细胞及其应用
|
|
CN121378506A
(zh)
*
|
2025-10-21 |
2026-01-23 |
北京京科信拓生物技术有限公司 |
表达car的免疫细胞及其应用
|